CYTOPHAGE
Live / Applied — Second extension granted (statement of use) (as of 29 Oct 2025)
What this means for you
Not registered yet, but its 24 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98149352
- Mark type
- Stylized text
- Filed
- 24 Aug 2023
- Published for opposition
- 22 Oct 2024
- Attorney of record
- Donna F. Schmitt
Goods and services
- Class 005 — Pharmaceuticals: natural, modified, and synthetic bacteriophage for medical purposes; medicated preparations, namely, vaccines, oral, and injectable antimicrobial preparations for the prevention, treatment, and control of infectious diseases in humans; veterinary preparations, namely, vaccines, oral, and injectable antimicrobial preparations for the prevention, treatment, and control of infectious diseases in animals; crop antimicrobial preparations, namely, crop sprays and soil additives for the prevention, treatment, and control of infectious diseases in crops; sanitizing preparations for hospital equipment, namely, instruments, beds, curtains, floors and counters; sanitizing preparations used to spray for surfaces in human health transport vehicles; sanitizing preparations for food and food processing industries; sanitizing preparations for veterinary hospital equipment, namely, instruments, beds, curtains, counters and floors; sanitizing preparations used to spray for surfaces in animal transport vehicles; sanitizing preparations for food processing facility surfaces, equipment, tools, floors, animal and crop transport vehicles; sanitizing preparations used in crop processing facilities for spraying on agricultural products; sanitizing preparations used for spraying on barn surfaces, equipment, floors, and tools
- Class 042 — Scientific and technological services: research and product development of antimicrobial preparations for the prevention, treatment and control of infectious diseases in humans, animals, and plants; research and development of natural, modified and synthetic bacteriophage for the prevention, treatment and control of infectious diseases in humans, animals and plants; bacteriological research; providing medical research information and scientific research information in the field of bacteriophage and clinical trials
Owner
- Cytophage Technologies Inc., Winnipeg, Manitoba, CA
- Cytophage Technologies Inc., Winnipeg, Manitoba, CA
Prosecution history
- 30 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Oct 2025 — SOU EXTENSION 2 GRANTED
- 29 Oct 2025 — SOU EXTENSION 2 FILED
- 29 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Apr 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Apr 2025 — SOU EXTENSION 1 GRANTED
- 24 Apr 2025 — SOU EXTENSION 1 FILED
- 24 Apr 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Apr 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 10 Apr 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Apr 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Apr 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 03 Dec 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2024 — PUBLISHED FOR OPPOSITION